Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Tivic Health Systems's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $3.58 Mil. Tivic Health Systems's Total Assets for the quarter that ended in Dec. 2023 was $5.16 Mil.
Therefore, Tivic Health Systems's Equity to Asset Ratio for the quarter that ended in Dec. 2023 was 0.69.
The historical rank and industry rank for Tivic Health Systems's Equity-to-Asset or its related term are showing as below:
TIVC'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.77 Med: 0.69 Max: 0.88
Current: 0.69
During the past 5 years, the highest Equity to Asset Ratio of Tivic Health Systems was 0.88. The lowest was -0.77. And the median was 0.69.
TIVC's Equity-to-Asset is ranked better than 56.45% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 0.65
vs TIVC: 0.69
Tivic Health Systems Equity-to-Asset Historical Data
The historical data trend for Tivic Health Systems's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Tivic Health Systems's Equity-to-Asset
For the Medical Devices subindustry, Tivic Health Systems's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tivic Health Systems's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tivic Health Systems's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Tivic Health Systems's Equity-to-Asset falls into.
Tivic Health Systems Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Tivic Health Systems's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tivic Health Systems (NAS:TIVC) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Tivic Health Systems Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Tivic Health Systems's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Tivic Health Systems (Tivic Health Systems) Business Description
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TIVC has been successfully added to your 